NBER Working Papers by Matthew Higgins
Contact and additional information for this author
•
All publications
•
Working Papers only
Working Papers
| June 2011 | Regulation and Welfare: Evidence from Paragraph IV Generic Entry in the Pharmaceutical Industry
with Lee G. Branstetter, Chirantan Chatterjee: w17188
With increasing frequency, generic drug manufacturers in the United States are able to challenge the monopoly status of patent-protected drugs even before their patents expire. The legal foundation for these challenges is found in Paragraph IV of the Hatch-Waxman Act. If successful, these Paragraph IV challenges generally lead to large market share losses for incumbents and sharp declines in average market prices. This paper estimates, for the first time, the welfare effects of accelerated generic entry via these challenges. Using aggregate brand level sales data between 1997 and 2008 for hypertension drugs in the U.S. we estimate demand using a nested logit model in order to back out cumulated consumer surplus, which we find to be approximately $270 billion. We then undertake a count... |
| December 2008 | Conveying Quality and Value in Emerging Industries: Star Scientists and the Role of Learning in Biotechnology
with Paula E. Stephan, Jerry G. Thursby: w14602
Managers of private entrepreneurial firms face obstacles in raising capital both in placing a value on a firm and conveying value to investors. These problems are exacerbated when the firm is small, has limited assets (except for human capital) and has yet to have a lead product. In such cases metrics are necessary to convey the value of the firm to investors. Here we explore the importance within the biotechnology industry of the non-financial metrics firms used to convey value during two important initial public offerings (IPO) windows (1989 to 1992 and 1996 to 2000). We also examine whether there was a change over time in the importance of various metrics in determining the value of a biotechnology firm. We find that firms with an affiliated Nobel laureate succeeded in raising the ... |
| July 1999 | Explaining Inequality the World Round: Cohort Size, Kuznets Curves, andOpenness
with Jeffrey G. Williamson: w7224
Klaus Deininger and Lyn Squire have recently produced an inequality data base for a panel of countries from the 1960s to the 1990s. We use these data to decompose the sources of inequality into three central parts: the demographic or cohort size effect; the so-called Kuznets Curve or demand effects; and the commitment to globalization or policy effects. We also control for education supply, the so-called natural resource curse and other variables suggested by the literature. While the Kuznets Curve comes out of hiding when the inequality relationship is conditioned by the other two, cohort size seems to be the most important force at work. We resolve the apparent conflict between this macro finding on cohort size and the contrary implications of recent research based on micro data. |
| May 1996 | Asian Demography and Foreign Capital Dependence
with Jeffrey G. Williamson: w5560
Ansley Coale and Edgar Hoover were right about Asia. Rising fertility and declining infant mortality have had a profound impact on Asian savings, investment and foreign capital dependency since Coale and Hoover wrote in 1958. We argue that: Much of the impressive rise in Asian savings rates since the 1960s can be explained by the equally impressive decline in youth dependency burdens; Where Asia has kicked the foreign capital dependence habit is where youth dependency burdens have fallen most dramatically; Aging will not diminish Japan's capacity to export capital in the next century, but little of it will go to the rest of Asia since the rest will become net capital exporters, at least if demography is allowed to have its way. These conclusions emerge from a model which rejects steady-... |
Contact and additional information for this author
•
All publications
•
Working Papers only
|
|
About
Support
The research activities of the NBER are funded by grants from federal research agencies, by private foundations, and by generous donations from our corporate associates and from private individuals. The NBER is a non-profit, 501(c)(3) organization. For information on supporting the NBER, please contact:
Mr. Denis Healy, Director of Development
NBER
1050 Massachusetts Avenue
Cambridge, MA 02138-5398
ph: 617-868-3900
email: dhealy@nber.org
Close